PHARMACEUTICAL PRODUCT DEVELOPMENT INC Financing Cash Flow
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Financing Cash Flow of -$220.11 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) financing activities for the quarter ending 2011-09-30 was -$5.09M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) financing activities for the quarter ending 2011-06-30 was -$7.18M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) financing activities for the quarter ending 2011-03-31 was -$207.84M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) financing activities for the quarter ending 2010-12-31 was -$14.10M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) financing activities for fiscal 2010 was -$155.94M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) financing activities for fiscal 2009 was -$55.39M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) financing activities for fiscal 2008 was -$111.11M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2011-09-30 | -$5.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$12.27M derived: sum of 2 quarters · filed 2011-11-02 | -$220.11M 10-Q · filed 2011-11-02 | -$234.20M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-06-30 | -$7.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | -$215.02M 10-Q · filed 2011-08-04 | -$229.11M derived: sum of 3 quarters · filed 2011-08-04 | -$241.65M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-03-31 | -$207.84M 10-Q · filed 2011-05-03 | -$221.93M derived: sum of 2 quarters · filed 2011-05-03 | -$234.47M derived: sum of 3 quarters · filed 2011-11-02 | -$350.68M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-12-31 | -$14.10M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | -$26.64M derived: sum of 2 quarters · filed 2011-11-02 | -$142.84M derived: sum of 3 quarters · filed 2011-11-02 | -$155.94M 10-K · filed 2011-02-25 |
| 2010-09-30 | -$12.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$128.75M derived: sum of 2 quarters · filed 2011-11-02 | -$141.84M 10-Q · filed 2011-11-02 | -$158.26M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-06-30 | -$116.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | -$129.30M 10-Q · filed 2011-08-04 | -$145.72M derived: sum of 3 quarters · filed 2011-08-04 | -$158.43M derived: sum of 4 quarters · filed 2011-08-04 |
| 2010-03-31 | -$13.09M 10-Q · filed 2011-05-03 | -$29.51M derived: sum of 2 quarters · filed 2011-05-03 | -$42.23M derived: sum of 3 quarters · filed 2011-05-03 | |
| 2009-12-31 | -$16.42M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | -$29.13M derived: sum of 2 quarters · filed 2011-02-25 | -$55.39M 10-K · filed 2011-02-25 | |
| 2009-09-30 | -$12.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | -$38.97M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | -$26.26M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | -$111.11M 10-K · filed 2011-02-25 |